Press Releases | Medtronic

Month Year

Email alerts

Jul 11, 2016

FDA Clears Expanded Indications for Medtronic NuVent(TM) EM Sinus Dilation System with Image Guidance

Clinical Study Conducted on Revision Subjects Support Expanded Indication for Patients with Previously Surgically Altered Tissue

DUBLIN - July 11, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) clearance of NuVent(TM), an EM sinus dilation system, for patients with scarred,...
Jun 27, 2016

Medtronic to Expand Heart Failure Portfolio with Acquisition of Heartware International

Extends Clinical and Commercial Leadership Into Growing Circulatory Support Sector

DUBLIN and FRAMINGHAM, Mass. - June 27, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, and HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of...
Jun 24, 2016

Medtronic Announces Double-Digit Increase in Cash Dividend; Reaches 40 Percent Payout Ratio

DUBLIN - June 24, 2016 - The board of directors of Medtronic plc (NYSE: MDT) today approved a 13 percent increase in its quarterly cash dividend, raising the quarterly amount to $0.43 per ordinary...
Jun 23, 2016

World Stroke Organization and Medtronic Collaborate to Increase Stroke Awareness

The World Stroke Organization (WSO) today announced a global partnership with Medtronic plc (NYSE:MDT) to increase stroke awareness through several initiatives. The two organizations will work...
Jun 18, 2016

Material in Medtronic Leads Inducted into Space Technology Hall of Fame®

Medtronic Applied NASA Technology into Its Cardiac Devices

DUBLIN and COLORADO SPRINGS, COLO. - April 18, 2016 - The Space Foundation has inducted NASA Langley Research Center-Soluble Imide (LaRC-SI) - used in Medtronic plc (NYSE: MDT) leads connected to...
Jun 17, 2016

New Clinical Study Will Evaluate MRI-Guided Laser Ablation for a Common Form of Epilepsy

Drug-Resistant Mesial Temporal Lobe Epilepsy Is the Focus of Medtronic's SLATE Study

DUBLIN - June 17, 2016 - Medtronic plc (NYSE: MDT) announced today the U.S. Food and Drug Administration's (FDA) approval of the Investigational Device Exemption (IDE) application for the pivotal...
Jun 10, 2016

FIRE AND ICE Data Show Fewer Repeat Ablations and Hospitalizations for AF Patients Treated with Medtronic Cryoballoon

Secondary Analyses Presented at Cardiostim 2016 Highlight Positive, Real-World Patient Outcomes

DUBLIN AND NICE, FRANCE - June 10, 2016 - Medtronic plc (NYSE: MDT) today announced findings from the secondary analyses of the FIRE AND ICE clinical trial that demonstrate significantly fewer...
Jun 10, 2016

Medtronic Converts 125 Million Patient Days of Data Into Personalized Insights That Improve Diabetes Management

CareLink® Portfolio Updates, IBM Watson Partnership Progress and New Strategic Alliances Delivering Intelligent Data and Actionable Information at ADA 2016

DUBLIN and NEW ORLEANS - June 10, 2016 - Delivering on its vision to transform care for the millions currently living with diabetes through intelligent data, Medtronic plc (NYSE:MDT) announced new...
Jun 9, 2016

First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study

First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study

DUBLIN and SIOUX FALLS, S.D. - February 9, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions and Sanford Health, one of the nation's largest health...
Jun 9, 2016

New Data Further Demonstrate Safety Benefits for World's Smallest Pacemaker

Data Featured In Late-Breaking Trial Session at Cardiostim 2016 Show Micra TPS Safety Benefits Maintained Beyond Six Months

DUBLIN and NICE, FRANCE - JUNE 9, 2016 - Medtronic plc (NYSE:MDT) today announced new results from the Medtronic Micra® Transcatheter Pacing System (TPS) Global Clinical Trial in a late-breaking...

Show per page